Free 7-day Trial
All Articles and Columns »

Guru Stocks at 52-Week Low: Deutsche Telekom AG, Baxter International Inc., Cephalon Inc., Burger King Holdings Inc.

Last week's top stocks that reached their 52-week lows were Deutsche Telekom AG (DT), Baxter International Inc. (BAX), General Growth Properties Inc (GGP), Cephalon Inc. (CEPH), and Burger King Holdings Inc. (BKC).According to GuruFocus updates, these Guru stocks have reached their 52-week lows.

Last week's top two out of favor industries were the Banking and Fixed Line Telecommunication industries. 8 Banking stocks have reached their 52-week lows, while 6 have reached their 52-week highs, giving the company a low/high ratio of 1.33. In the Fixed Line Telecommunication industry, 1 stock has reached its 52-week low, while 2 have reached their 52-week highs, giving the company a low/high ratio of 0.5.

For full details about guru stocks at 52-week lows and more information, click here: http://www.gurufocus.com/52weeklow.php.

Deutsche Telekom AG (DT) Reached the 52-Week Low of $11.06

The prices of Deutsche Telekom AG (DT) shares have declined to close to the 52-week low of $11.06, which is 38.8% off the 52-week high of $17.75. Deutsche Telekom AG is owned by 1 Gurus we are tracking.

Deutsche Telekom is Europe's largest communications company and one of the largest communications carriers worldwide. Through T-Mobile Deutsche Telekom's mobile telephony subsidiary and through other subsidiaries and investments Deutsche Telekom serves mobile telephony customers worldwide. Deutsche Telekom offers its customers a complete range of fixed-line voice telephony products and services. Deutsche Telekom AG has a market cap of $48.24 billion; its shares were traded at around $11.06 with a P/E ratio of 21.3 and P/S ratio of 0.6. The dividend yield of Deutsche Telekom AG stocks is 7%. Deutsche Telekom AG had an annual average earning growth of 23.4% over the past 5 years.

DT recently reported its first quarter 2009 results. Reported revenue increased by 6.2 percent to EUR 15.9 billion. Adjusted net profit also decreased by 12.7%. The company of mobile customers that the company served increased 6.8%.

Charles Brandes owns 30,269,101 shares as of 03/31/2009, which accounts for 2.31% of the $16.16 billion portfolio of Brandes Investment.

Baxter International Inc. (BAX) Reached the 52-Week Low of $47.56

The prices of Baxter International Inc. (BAX) shares have declined to close to the 52-week low of $47.56, which is 33.6% off the 52-week high of $71.15. Baxter International Inc. is owned by 8 Gurus we are tracking. Among them, 1 has added to their positions during the past quarter. 8 reduced their positions.

Baxter engages in the worldwide development manufacture and distribution of a diversified line of products systems and services used primarily in the health-care field. The company's products are used by hospitals clinical and medical research laboratories blood and dialysis centers rehabilitation centers nursing homes doctors' offices and by patients at home under physician supervision. Baxter International Inc. has a market cap of $28.93 billion; its shares were traded at around $47.56 with a P/E ratio of 13.8 and P/S ratio of 2.3. The dividend yield of Baxter International Inc. stocks is 2.2%. Baxter International Inc. had an annual average earning growth of 4.8% over the past 10 years. GuruFocus rated Baxter International Inc. the business predictability rank of 4-star.

Baxter recently reported its results for the first quarter of 2009. The company said that it posted strong results of $0.83 per diluted share. The company also said that it would provides updated full-year outlook. “Despite the challenging, global macro-economic environment, our first quarter financial results underscore the value of our diversified healthcare model, the solid fundamentals underpinning our portfolio, and our disciplined focus on driving margin improvement,” said Robert L. Parkinson, Jr., chairman and chief executive officer. “We continue to believe that we are very well-positioned given our broad geographic reach and the medically-necessary nature of our portfolio to expand access to care, improve treatments and enhance the quality of life for patients around the world.”

Jean-Marie Eveillard bought 79,400 shares in the quarter that ended on 03/31/2009, which is 0.06% of the $7.39 billion portfolio of Arnhold & S. Bleichroeder Advisers, LLC. Dodge & Cox owns 7,428 shares as of 03/31/2009, a decrease of 21.21% of from the previous quarter. This position accounts for less than 0.01% of the $54.08 billion portfolio of Dodge & Cox. Ken Heebner owns 4,027,700 shares as of 03/31/2009, a decrease of 34.91% of from the previous quarter. This position accounts for 3.82% of the $5.4 billion portfolio of CAPITAL GROWTH MANAGEMENT LP. Richard Aster Jr owns 199,300 shares as of 03/31/2009, a decrease of 35.79% of from the previous quarter. This position accounts for 0.6% of the $1.69 billion portfolio of Meridian Fund. Lee Ainslie sold out his holdings in the quarter that ended on 03/31/2009.

Many insiders are selling the company. These include a Director and two Corporate Vice Presidents of the company. Director Thomas T Stallkamp sold 10,590 shares of BAX stock on 02/12/2009 at the average price of $58.52. [/color] Corporate Vice President Norbert G Riedel sold 102,300 shares of BAX stock on 01/27/2009 at the average price of $58.07; the price of the stock has decreased by 18.1% since. Corporate Vice President John J Greisch sold 119,000 shares of BAX stock on 01/26/2009 at the average price of $57.81; the price of the stock has decreased by 17.73% since.

Cephalon Inc. (CEPH) Reached the 52-Week Low of $57.09

The prices of Cephalon Inc. (CEPH) shares have declined to close to the 52-week low of $57.09, which is 29.9% off the 52-week high of $80.26. Cephalon Inc. is owned by 4 Gurus we are tracking. Among them, 1 has added to their positions during the past quarter. 3 reduced their positions.

Cephalon is an international biopharmaceutical company focused on thediscovery development and marketing of products to treat sleep disordersneurological disorders cancer and pain. In addition to an active research and development program they market products in the United States and various countries in Europe. Cephalon Inc. has a market cap of $3.93 billion; its shares were traded at around $57.09 with a P/E ratio of 11.3 and P/S ratio of 2. Cephalon Inc. had an annual average earning growth of 10.1% over the past 5 years.

Cephalon recently reported its first quarter 2009 results. The company announced that its sales were $514 million for the quarter, up from $434 million in the first quarter of 2008. For the second quarter of 2009, the company is introducing and sales guidance of $515 to $535 million.

Jean-Marie Eveillard bought 710 shares in the quarter that ended on 03/31/2009, which is less than 0.01% of the $7.39 billion portfolio of Arnhold & S. Bleichroeder Advisers, LLC. Edward Owens owns 1,402,000 shares as of 03/31/2009, which accounts for 0.61% of the $15.69 billion portfolio of Vanguard Health Care Fund. Ken Heebner owns 230,000 shares as of 03/31/2009, a decrease of 30.3% of from the previous quarter. This position accounts for 0.29% of the $5.4 billion portfolio of CAPITAL GROWTH MANAGEMENT LP. Richard Aster Jr owns 217,200 shares as of 03/31/2009, a decrease of 40.8% of from the previous quarter. This position accounts for 0.87% of the $1.69 billion portfolio of Meridian Fund.

Sell: EVP, WW Pharm Ops Robert P Jr Roche sold 23,920 shares of CEPH stock on 12/22/2008 at the average price of $77.17; the price of the stock has decreased by 26.02% since.

Burger King Holdings Inc. (BKC) Reached the 52-Week Low of $16.89

The prices of Burger King Holdings Inc. (BKC) shares have declined to close to the 52-week low of $16.89, which is 46.5% off the 52-week high of $30.31. Burger King Holdings Inc. is owned by 2 Gurus we are tracking. Among them, 1 has added to their positions during the past quarter. 1 reduced their positions.

Burger King Holdings Inc. through its subsidiaries owns and franchises fast food hamburger restaurants. The company offers various food items such as flame-broiled hamburgers chicken and other specialty sandwiches french fries and soft drinks. Approximately 90 percent of BURGER KING ? restaurants are owned and operated by independent franchisees many of them family-owned operations that have been in business for decades. Burger King Holdings has operations in the United States Canada Europe the Middle East Africa the Asia Pacific and Latin America. Burger King Holdings Inc. has a market cap of $2.27 billion; its shares were traded at around $16.89 with a P/E ratio of 11.9 and P/S ratio of 0.9. The dividend yield of Burger King Holdings Inc. stocks is 1.5%.

Burger King recently reported its fiscal third quarter 2009 results. The company announced that its revenue for the quarter was $600 million, up 1% compared to revenues a year ago. The company also announced that this was its 21 st consecutive quarter of worldwide positive sales, and 20 th consecutive quarter of U.S and Canada positive sales. “We continue to post top-line growth even in this challenging macroeconomic environment,” said John Chidsey, chairman and chief executive officer, Burger King Corp. “We delivered our 21 st consecutive quarter of worldwide positive comp sales, our annual net restaurant growth remains on track and our cash flow generation remains strong.

Richard Aster Jr bought 328,300 shares in the quarter that ended on 03/31/2009, which is 0.45% of the $1.69 billion portfolio of Meridian Fund. Robert Olstein owns 240,000 shares as of 03/31/2009, a decrease of 40.92% of from the previous quarter. This position accounts for 1.34% of the $411 million portfolio of Olstein Financial Alert Fund.

Many insiders are recently buying the company.


Rating: 4.6/5 (7 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide